ATA Guidelines Tools

Preoperative Imaging

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/631770

Contents of this Issue

Navigation

Page 1 of 7

Î Though thyroid cancer is associated with high overall survival rates, exceeding 90% for most subtypes, the risk of recurrence has been reported to be as high as 35%. Î Most of these recurrences are detected within the first five years after diagnosis and thus may actually represent persistent rather than truly recurrent disease. Î It is known that the majority of reoperations for thyroid cancer are preventable and that inadequate preoperative imaging frequently is the root cause of incomplete initial surgery. Î Ultrasound remains the most important imaging modality in the evaluation of thyroid cancer and should be used routinely to assess both the primary tumor and all associated cervical lymph node basins preoperatively. Î Ultrasound evaluation (''mapping'') of bilateral lymph node compartments 1–6 should be performed routinely in the preoperative evaluation of patients with definitive cytologic evidence of carcinoma (positive FNA). Î Screening for distant metastasis is generally not performed prior to initial surgery for differentiated thyroid cancers. Functional Imaging Î Functional imaging with positron emission tomography (PET), PET-CT or PET- 18 F-fluoro-2-deoxyglucose is currently limited to the detection of recurrent disease. Key Points Diagnosis

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Preoperative Imaging